Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (Weighted Average) (2019 - 2025)

Volitionrx's Shares Outstanding (Weighted Average) history spans 9 years, with the latest figure at $36.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 316.98% year-over-year to $36.3 million; the TTM value through Dec 2025 reached $36.3 million, up 316.98%, while the annual FY2025 figure was $36.3 million, 316.98% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $36.3 million in Q4 2025 per VNRX's latest filing, down from $48.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $87.9 million in Q3 2024 to a low of $862500.0 in Q4 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $52.8 million, with a median of $53.2 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Weighted Average): surged 909.37% in 2024, then crashed 55.73% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $52.7 million in 2021, then increased by 3.7% to $54.6 million in 2022, then crashed by 98.42% to $862500.0 in 2023, then soared by 909.37% to $8.7 million in 2024, then soared by 316.98% to $36.3 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Shares Outstanding (Weighted Average) are $36.3 million (Q4 2025), $48.0 million (Q3 2025), and $47.3 million (Q2 2025).